Cardiac fibroblasts regulate cardiomyocyte hypertrophy through dynamic regulation of type I collagen

Rationale Cardiomyocytes and fibroblasts in the heart communicate through both secreted growth factors as well as through sensing the structural properties of the extracellular matrix that each helps generate. Previous studies have shown that defects in fibroblast activity during disease stimulation result in altered cardiomyocyte hypertrophy, although the role that collagen might play in this communication is unknown. Objective Here we investigated how type I collagen maturation and disease-responsive matrix expansion in the heart by cardiac fibroblasts impacts cardiac fibrosis and cardiomyocyte hypertrophy. Methods and Results We generated and characterized Col1a2-/- mice using standard gene-targeting. Col1a2-/- mice were viable, although by young adulthood their hearts showed alterations in extracellular matrix mechanical properties, as well as an unanticipated activation of cardiac fibroblasts and induction of a progressive fibrotic response. This included increases in fibroblast number and a progressive cardiac hypertrophy, with reduced functional performance by 9 months. Col1a2-loxP targeted mice were also generated and crossed with the tamoxifen-inducible Postn-MerCreMer knock-in mice to delete the Col1a2 gene in myofibroblasts post-pressure overload injury, to more specifically implicate fibroblasts as effectors of cardiomyocyte hypertrophy in vivo. Opposite to the gradual induction of cardiac hypertrophy observed in germline Col1a2-/- mice as they matured developmentally, adult fibroblast-specific deletion of Col1a2 during pressure overload protected these mice from cardiac hypertrophy in the first week with a delayed fibrotic response. However, this reduction in hypertrophy due to myofibroblast-specific Col1a2 deletion was gradually lost over 2 and 6 weeks of pressure overload as augmented fibrosis returned. Conclusions Defective type I collagen in the developing heart alters the structural integrity of the extracellular matrix that leads to fibroblast expansion, activation, fibrosis and hypertrophy with progressive cardiomyopathy in adulthood. However, acute deletion of type I collagen production for the first time in the adult heart during pressure overload prevents ECM expansion and inhibits cardiomyocyte hypertrophy, while gradual restoration of fibrosis again permitted hypertrophy comparable to controls.

[1]  Stephanie L. K. Bowers,et al.  Fibroblasts orchestrate cellular crosstalk in the heart through the ECM , 2022, Nature Cardiovascular Research.

[2]  Kirk C. Hansen,et al.  A mass spectrometry-based atlas of extracellular matrix proteins across 25 mouse organs , 2022, bioRxiv.

[3]  K. Yutzey,et al.  Periostin-expressing Schwann cells and endoneurial cardiac fibroblasts contribute to sympathetic nerve fasciculation after birth. , 2021, Journal of molecular and cellular cardiology.

[4]  J. Molkentin,et al.  Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart , 2019, JCI insight.

[5]  N. Frangogiannis The Extracellular Matrix in Ischemic and Nonischemic Heart Failure. , 2019, Circulation research.

[6]  N. Frangogiannis Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. , 2019, Molecular aspects of medicine.

[7]  J. Molkentin,et al.  Myofibroblast-Specific TGF&bgr; Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy , 2018, Circulation research.

[8]  J. Molkentin,et al.  Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure , 2018, Circulation.

[9]  J. Molkentin,et al.  Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis. , 2017, The Journal of clinical investigation.

[10]  J. Myllyharju,et al.  Structural basis of homo- and heterotrimerization of collagen I , 2017, Nature Communications.

[11]  B. Aronow,et al.  Genetic lineage tracing defines myofibroblast origin and function in the injured heart , 2016, Nature Communications.

[12]  F. Kajiya,et al.  Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophied rat hearts induced by chronic β-adrenergic stimulation. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[13]  E. Olson,et al.  The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors , 2012, Development.

[14]  Alexandra Naba,et al.  Overview of the matrisome--an inventory of extracellular matrix constituents and functions. , 2012, Cold Spring Harbor perspectives in biology.

[15]  Z. Werb,et al.  Extracellular matrix degradation and remodeling in development and disease. , 2011, Cold Spring Harbor perspectives in biology.

[16]  John A Pearce,et al.  Dynamic correction for parallel conductance, GP, and gain factor, alpha, in invasive murine left ventricular volume measurements. , 2009, Journal of applied physiology.

[17]  R. Patten,et al.  Small animal models of heart failure: development of novel therapies, past and present. , 2009, Circulation. Heart failure.

[18]  Michael N. Wosczyna,et al.  A multifunctional reporter mouse line for Cre‐ and FLP‐dependent lineage analysis , 2009, Genesis.

[19]  C. Eyers Universal sample preparation method for proteome analysis , 2009 .

[20]  G. Dorn,et al.  Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling , 2007, Circulation research.

[21]  A. Ramamurthi,et al.  Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues , 2007, Journal of cellular biochemistry.

[22]  I. Medugorac,et al.  Characterization of intramuscular collagen in the mammalian left ventricle , 1982, Basic Research in Cardiology.

[23]  Jian Xu,et al.  Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy , 2004, Circulation research.

[24]  Hiroshi Asanuma,et al.  Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy , 2002, Nature Medicine.

[25]  A D McCulloch,et al.  Myocardial Mechanics and Collagen Structure in the Osteogenesis Imperfecta Murine (oim) , 2000, Circulation research.

[26]  M T Davisson,et al.  Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Mcgaw,et al.  Turnover rates of different collagen types measured by isotope ratio mass spectrometry. , 1992, Biochimica et biophysica acta.

[28]  J. Uitto Collagen polymorphism: isolation and partial characterization of alpha 1(I)-trimer molecules in normal human skin. , 1979, Archives of biochemistry and biophysics.

[29]  S. Jimenez,et al.  Identification of collagen alpha1(I) trimer in embryonic chick tendons and calvaria. , 1977, Biochemical and biophysical research communications.